Integra LifeSciences to Present at Healthcare Conferences in June 2018
Wednesday, June 6, 2018at 3:30 p.m. ET, Peter Arduini, president and chief executive officer, will present at the Jefferies2018 Healthcare Conference in New York, NY. The session will be available through live audio webcast and can be accessed from the Investor section of www.integralife.com.
Wednesday, June 20, 2018at 8:30 a.m. ET, Robert T. Davis, Jr., president – orthopedics & tissue technologies, will present at the JMP Securities Life Sciences Conferencein New York, NY.
Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item 1A of Integra's Annual Report on Form 10-K for the year ended
|Investor Relations Contacts:|
|Vice President, Treasury & Investor Relations|
|Director, Investor Relations|
|Senior Director, Global Corporate Communications|
Source: Integra LifeSciences Holdings Corporation